What to Say and How to Say It: Effective Communication for Cardiovascular Disease Prevention

Overview

Journal Curr Opin Cardiol

Specialty Cardiology & Vascular Diseases

Date 2016 Jul 19

PMID 27428113

Citations 18

Authors

Ann Marie Navar

Neil J Stone

Seth S Martin

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Current guidelines for cholesterol treatment emphasize the importance of engaging patients in a risk-benefit discussion prior to initiating statin therapy.

Recent Findings: Although current risk prediction algorithms are well defined, there is less data on how to communicate with patients about cardiovascular disease risk, benefits of treatment, and possible adverse effects.

Summary: We propose a four-part model for effective shared decision-making: 1) Assessing patient priorities, perceived risk, and prior experience with cardiovascular risk reduction; 2) Arriving at a recommendation for therapy based on the patient's risk of disease, guideline recommendations, new clinical trial data, and patient preferences; 3) Communicating this recommendation along with risks, benefits, and alternatives to therapy following best practices for discussing numeric risk; and 4) Arriving at a shared decision with the patient with ongoing reassessment as risk factors and patient priorities change.

Citing Articles

Risk of Cardiovascular Events in Adults Aged 40 to 79 Years with Diagnosed Hypertension, High Cholesterol, and/or Diabetes but Not on Medications: Findings from Nationwide Cross-Sectional Studies.

Wang S, Qu Y, Zhang J, Xue X, Yang Z J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330326 PMC: 11432436. DOI: 10.3390/jcdd11090268.

Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward.

Sigala E, Panagiotakos D Curr Cardiol Rev. 2024; 20(6):e030724231561.

PMID: 38963102 PMC: 11440323. DOI: 10.2174/011573403X311031240703080650.

Cardiovascular disease risk communication and prevention: a meta-analysis.

Bakhit M, Fien S, Abukmail E, Jones M, Clark J, Scott A Eur Heart J. 2024; 45(12):998-1013.

PMID: 38243824 PMC: 10972690. DOI: 10.1093/eurheartj/ehae002.

Awareness of cardiovascular risk among persons with type 2 diabetes: a qualitative study.

Jutterstrom L, Stenlund A, Otten J, Lilja M, Angerud K Int J Qual Stud Health Well-being. 2023; 19(1):2294512.

PMID: 38112175 PMC: 11737827. DOI: 10.1080/17482631.2023.2294512.

Cardiovascular disease threat and perceived efficacy of selected preventive behaviors among Polish men: an analysis based on the extended parallel process model.

Domoslawska-Zylinska K, Wlodarczyk D, Krysinska-Pisarek M Front Public Health. 2023; 11:1244302.

PMID: 38026338 PMC: 10679673. DOI: 10.3389/fpubh.2023.1244302.

References

Loon M, van der Weijden T, Ronda G, van Steenkiste B, Winkens B, Elwyn G . Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Prev Med. 2009; 50(1-2):35-44. DOI: 10.1016/j.ypmed.2009.11.007. View

Frijling B, Lobo C, Keus I, Jenks K, Akkermans R, Hulscher M . Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns. 2004; 52(1):47-53. DOI: 10.1016/s0738-3991(02)00248-3. View

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L . Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016; 374(21):2021-31. DOI: 10.1056/NEJMoa1600176. View

Frileux S, Munoz Sastre M, Mullet E, Sorum P . The impact of the preventive medical message on intention to change behavior. Patient Educ Couns. 2004; 52(1):79-88. DOI: 10.1016/s0738-3991(03)00003-x. View

Goff Jr D, Lloyd-Jones D, Bennett G, Coady S, DAgostino R, Gibbons R . 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S49-73. DOI: 10.1161/01.cir.0000437741.48606.98. View

Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M . Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil. 2010; 17(5):519-23. DOI: 10.1097/HJR.0b013e328337ccd3. View

Zipkin D, Umscheid C, Keating N, Allen E, Aung K, Beyth R . Evidence-based risk communication: a systematic review. Ann Intern Med. 2014; 161(4):270-80. DOI: 10.7326/M14-0295. View

Goldman R, Parker D, Eaton C, Borkan J, Gramling R, Cover R . Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med. 2006; 4(3):205-12. PMC: 1479442. DOI: 10.1370/afm.534. View

Stone N, Robinson J, Lichtenstein A, Merz C, Blum C, Eckel R . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 63(25 Pt B):2889-934. DOI: 10.1016/j.jacc.2013.11.002. View

10.

Catapano A, Reiner Z, De Backer G, Graham I, Taskinen M, Wiklund O . ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011; 217 Suppl 1:S1-44. DOI: 10.1016/j.atherosclerosis.2011.06.012. View

11.

Eckel R, Jakicic J, Ard J, de Jesus J, Miller N, Hubbard V . 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 63(25 Pt B):2960-84. DOI: 10.1016/j.jacc.2013.11.003. View

12.

Ford I, Murray H, McCowan C, Packard C . Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study. Circulation. 2016; 133(11):1073-80. PMC: 4894764. DOI: 10.1161/CIRCULATIONAHA.115.019014. View

13.

Edwards A, Thomas R, Williams R, Ellner A, Brown P, Elwyn G . Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial. Patient Educ Couns. 2006; 63(3):336-49. DOI: 10.1016/j.pec.2005.12.016. View

14.

Martin S, Sperling L, Blaha M, Wilson P, Gluckman T, Blumenthal R . Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines. J Am Coll Cardiol. 2015; 65(13):1361-1368. PMC: 4760944. DOI: 10.1016/j.jacc.2015.01.043. View

15.

Fair A, Murray P, Thomas A, Cobain M . Using hypothetical data to assess the effect of numerical format and context on the perception of coronary heart disease risk. Am J Health Promot. 2008; 22(4):291-6. DOI: 10.4278/061030140R2.1. View

16.

Schwartz L, Woloshin S, Black W, Welch H . The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997; 127(11):966-72. DOI: 10.7326/0003-4819-127-11-199712010-00003. View

17.

McCaul K, Branstetter A, Schroeder D, Glasgow R . What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996; 15(6):423-9. DOI: 10.1037//0278-6133.15.6.423. View

18.

Stacey D, Legare F, Col N, Bennett C, Barry M, Eden K . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014; (1):CD001431. DOI: 10.1002/14651858.CD001431.pub4. View

19.

Goodyear-Smith F, Arroll B, Chan L, Jackson R, Wells S, Kenealy T . Patients prefer pictures to numbers to express cardiovascular benefit from treatment. Ann Fam Med. 2008; 6(3):213-7. PMC: 2384980. DOI: 10.1370/afm.795. View

20.

Samsa G, Cohen S, Goldstein L, Bonito A, Duncan P, Enarson C . Knowledge of risk among patients at increased risk for stroke. Stroke. 1997; 28(5):916-21. DOI: 10.1161/01.str.28.5.916. View